Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance

  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Flutamide Tablets 250 mg
  Indications :
 

For use in combination with LHRH agonists for the management of locally confined

Prostate carcinoma

Metastatic carcinoma 

   
  Dosage :
  The recommended dosage is 1-2 tablets 3 times a day at 8-hour intervals.

Dosage Adjustment :

Renal Impairment : Dosing adjustments for renal impairment  are not indicated for flutamide.

Hepatic Impairment :
Discontinue Flutamide if AST ≥ 2 x ULN or bilirubin is > ULN.
   
  Packing : 3 Strips of 10 Tablets
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.